Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to
In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of t
pharmaphorum editor in chief Jonah Comstock takes on the Health Innovators series with a conversation with Amy Bucher, chief behavioral officer at Lirio and author of “Engaged: Designing fo
Ensuring that patients remain consistent with their therapies is one of the major challenges facing healthcare, so what if you could make treatment a game?
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.